Skip to content

The effects of estrogen on blood coagulation, anticoagulation, and fibrinolysis in gynecologic benign diseases: A prospective study.

The effects of estrogen on blood coagulation, anticoagulation, and fibrinolysis in gynecologic benign diseases: A prospective study. - The effects of estrogen on blood coagulation, anticoagulation, and fibrinolysis in gynecologic benign diseases: A prospective study.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000044081
Enrollment
120
Registered
2021-05-10
Start date
2021-05-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gynecologic benign diseases

Interventions

None listed

Sponsors

Department of Obstetrics and Gynecology, Hamamatsu University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Patients who are diagnosed as uterine fibroids, adenomyosis, endometriosis, endometrial polyps, or ovarian cysts by gynecological practice with and without Gonadotropin releasing hormone agonist/antagonist. Patients during non-ovarian stimulation cycles. Patients during controlled ovarian hyperstimulation cycles.

Exclusion criteria

Exclusion criteria: Patients medicated with antiplatelets or anticoagulants. Patients affected by venous thromboembolism. Patients complicated with diseases involving platelets, coagulation, fibrinolysis, anticoagulation, or antifibrinolysis system. Patients with anemia (Hb< 8.0 g/dL). Patients after menopause. Patients with serious liver disease (or AST <= 100 U/L). Patients with severe renal disease (or serum creatinine <= 1.3 mg/dL). Pregnant women. Women during lactation.

Design outcomes

Primary

MeasureTime frame
The parameters of Rotational thromboelastometry and Endogenous thrombin potential-based activated protein C sensitivity ratio.

Countries

Japan

Contacts

Public ContactYusuke Todo

Hamamatsu University School of Medicine Department of Obstetrics and Gynecology

D21022@hama-med.ac.jp053-435-2309

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026